Anergic CD4+ T cells underlying impaired immune system in leukemia
Project/Area Number |
23791079
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Hematology
|
Research Institution | Osaka City University (2012) Kyoto University (2011) |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
Keywords | PD-1 / 白血病 / 免疫不全 / leukemia / immunosuppression / osteopontin / immunosenescence |
Research Abstract |
When normal young B6 mice were transplanted with leukemia cell lines, PD-1+ CD4+ T cells, which are hardly seen in young mice, were rapidly and robustly increased, and the response of CD4+ T cells to anti -CD3 mAb was profoundly depressed. PD-1+ CD4+ T cells were preferentially detected in the lymphoid tissues with leukemia involvement, suggesting that these T cells constituted a significant host component in leukemic tissues. They exhibited a genetic signature distinct from regular CD4+ T cells including the high expression of C/EBPα, which is normally expressed in myeloid lineage cells. Using TCR transgenic mice as recipients of leukemia, we confirmed that the PD-1+ CD4+ T cells were derived from memory phenotype, but not naive, population.
|
Report
(3 results)
Research Products
(7 results)